Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy-Reference-Cited by-同舟云学术

Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy

Published:2021-02-16 Issue:7 Volume:62 Page:1778-1781
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Przespolewski Amanda¹^ORCID,Muppidi Monica R.¹²,Freyer Craig W.³^ORCID,Ji Wenyan⁴,Cronin Tara L.¹,Thota Swapna¹,Griffiths Elizabeth A.¹,Thompson James E.¹,Ontiveros Evelena P.¹⁵,Baron Jeffrey⁶,Elshoury Amro¹,Wang Eunice S.¹

Affiliation:

1. Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

2. Department of Medicine, New York City Health + Hospitals, Bronx, NY, USA

3. Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

4. Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

5. Cancer Care Specialists of Illinois, Decatur, IL, USA

6. Department of Pharmacy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1885654

Reference15 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms

3. Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms

4. Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure

5. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukem

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Nanoparticles for Skin Protection — A Review;Nano LIFE;2024-08-09

2. Cladribine, cytarabine, and filgrastim based regimen in relapsed or refractory acute myeloid leukemia: A systematic review and meta-analysis;Medicine;2023-11-03

3. Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia;Current Hematologic Malignancy Reports;2021-09-09